Elicio Therapeutics Inc. (ELTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.46M
Last updated: Nov 17, 2026 at 11:02 AM ET
Elicio Therapeutics Inc. (ELTX) Earnings: Report Dates and Results
Elicio Therapeutics (ELTX) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Elicio Therapeutics reported EPS of -$0.30, above the -$0.42 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ELTX has an expected report date of Mar 10, 2027.
Earnings History
Of the 17 quarters below that had an estimate, ELTX beat 6, missed 10 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 124.36% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.30 | -$0.42 | -$0.48 - -$0.40 | +28.57% | Beat | N/A | 4 | 0 up, 0 down | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$0.43 | -$0.53 | -$0.60 - -$0.45 | +18.87% | Beat | N/A | 4 | N/A | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$0.65 | -$0.46 | -$0.49 - -$0.44 | -41.30% | Miss | N/A | 2 | 0 up, 1 down | May 11, 2026 | N/A |
| Dec 31, 2025 | -$0.49 | -$0.45 | -$0.47 - -$0.42 | -10.11% | Miss | N/A | 2 | 1 up, 0 down | Mar 12, 2026 | N/A |
| Sep 30, 2025 | -$0.60 | -$0.48 | -$0.48 - -$0.48 | -25.00% | Miss | N/A | 1 | 0 up, 1 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.66 | -$0.69 | -$0.69 - -$0.68 | +4.35% | Beat | N/A | 2 | 0 up, 0 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.87 | -$0.83 | -$1.15 - -$0.64 | -4.82% | Miss | N/A | 3 | 0 up, 1 down | May 13, 2025 | N/A |
| Dec 31, 2024 | -$1.02 | -$0.88 | -$0.99 - -$0.76 | -16.57% | Miss | N/A | 2 | N/A | Mar 31, 2025 | $1.17M |
| Sep 30, 2024 | -$1.39 | -$0.73 | -$0.95 - -$0.57 | -90.41% | Miss | N/A | 3 | 1 up, 1 down | Nov 13, 2024 | N/A |
| Jun 30, 2024 | -$0.64 | -$0.96 | -$1.04 - -$0.88 | +33.33% | Beat | N/A | 2 | 0 up, 0 down | Aug 13, 2024 | N/A |
| Mar 31, 2024 | -$1.15 | -$1.09 | -$1.21 - -$0.97 | -5.50% | Miss | N/A | 2 | 1 up, 0 down | May 15, 2024 | N/A |
| Dec 31, 2023 | -$1.75 | -$0.78 | -$1.03 - -$0.54 | -124.36% | Miss | N/A | 2 | 0 up, 0 down | Feb 13, 2024 | N/A |
| Sep 30, 2023 | -$1.27 | -$0.80 | N/A | -58.75% | Miss | N/A | N/A | N/A | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$2.44 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 11, 2023 | N/A |
| Mar 31, 2023 | -$1.51 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 10, 2023 | N/A |
| Dec 31, 2022 | -$2.10 | -$2.10 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 29, 2023 | N/A |
| Sep 30, 2022 | -$3.00 | -$3.60 | N/A | +16.67% | Beat | N/A | N/A | N/A | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$3.00 | -$4.63 | N/A | +35.21% | Beat | N/A | N/A | N/A | Aug 16, 2022 | N/A |
| Mar 31, 2022 | -$4.80 | -$4.35 | N/A | -10.34% | Miss | N/A | N/A | N/A | Jun 29, 2022 | $1.65M |
| Sep 30, 2021 | -$5.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 | $1.46M |
| Jun 30, 2021 | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2021 | $540000 |
| Mar 31, 2021 | -$15.65 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2021 | $371000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.62, after -$4.20 the year before. It was -$34.26 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.62 | N/A |
| Dec 31, 2024 | -$4.20 | N/A |
| Dec 31, 2023 | -$6.96 | N/A |
| Dec 31, 2022 | -$34.26 | N/A |
Frequently Asked Questions About ELTX
When is Elicio Therapeutics's next earnings date?
Elicio Therapeutics's next earnings report is expected for Mar 10, 2027.
Did ELTX beat earnings estimates last quarter?
Yes. Elicio Therapeutics reported EPS of -$0.30 for the quarter ended Sep 30, 2026, above the -$0.42 estimate, a 28.57% surprise.
What EPS do analysts expect from ELTX next quarter?
The consensus EPS estimate for Elicio Therapeutics for the quarter ending Dec 31, 2026 is -$0.35 from 6 analysts, with estimates from -$0.41 to -$0.33.
How often does ELTX beat earnings estimates?
Elicio Therapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -5.75%.
ELTX pages: Overview, Earnings, Forecast, Financials, Competitors